Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center

Biologics are important treatment options for psoriasis; however, direct comparison of their efficacy, safety, and drug survival is insufficient in clinical practice. This retrospective single-center study aimed to compare the efficacy, safety, and drug survival of three commonly used psoriasis biol...

Full description

Bibliographic Details

Published in:	Biomedicines
Main Authors:	Seung-Won Jung, Sung Ha Lim, Jae Joon Jeon, Yeon-Woo Heo, Mi Soo Choi, Seung-Phil Hong
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Subjects:	psoriasis direct comparison in real world secukinumab ustekinumab guselkumab
Online Access:	https://www.mdpi.com/2227-9059/10/5/1058